Guardant Health
GH
#1543
Rank
NZ$23.18 B
Marketcap
NZ$178.52
Share price
-0.92%
Change (1 day)
186.60%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company